Delivery Order SPE2DR25D1034-SPE2DR26FPY0G
Award Date 3/2/26
Potential Completion Date 3/23/26
Potential Value $8.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued an $8,555.21 delivery order to AmerisourceBergen Drug Corp on March 2, 2026, for Ibrance 125 mg tablets (7-count). The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for Ibrance 125 mg capsules (21-count), with a ceiling value of $8,555.21. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 and running through December 2026.</p> <p>Place of performance is Conshohocken, PA 19428. Ultimate completion date is March 23, 2026. Pricing is firm fixed price. No set-aside was applied.</p>
- The Defense Logistics Agency issued a $25,665.63 delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for supply of Ibrance 125 mg tablets (7s). This delivery order is issued under the DLA Troop Support Medical indefinite delivery contract (IDC) with Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 2026. The contract provides pharmaceutical and medical supplies to support military healthcare programs worldwide. Place of performance is Conshohocken,...
- The Defense Logistics Agency issued a $8,555.21 delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for Ibrance 125 mg capsule supply (21-count packages), with completion required by March 24, 2026. Place of performance is Conshohocken, PA. The order was priced firm fixed price and carried no set-aside. This delivery order is issued against Amerisourcebergen Drug Corp's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 18, 2026, with a ceiling value of $34,239.36 for supply of Ibrance 100 mg capsules (21-count packaging). Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 11, 2026. Pricing is firm fixed price. The delivery order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued...
- The Defense Logistics Agency issued a $8,559.84 delivery order to Amerisourcebergen Drug Corp on February 17, 2026, for Ibrance 100 mg tablets. Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 10, 2026, and is priced as firm fixed price with no set-aside. The delivery order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which supports pharmaceutical supply...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 20, 2026, for Ibrance 125 mg capsule 21-count units, with a ceiling value of $8,555.21. Place of performance is Conshohocken, PA. The order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. Ultimate completion date is March 13, 2026. Pricing is firm fixed price under a non-set-aside competitive...
- The Defense Logistics Agency issued a $8,559.84 delivery order to Amerisourcebergen Drug Corp on February 24, 2026, for Ibrance 100 mg tablets. Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 17, 2026. Pricing is firm fixed price. The order was issued under a parent Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999 through December 2026, which supports global pharmaceutical supply to military healthcare...
- The Defense Logistics Agency issued a $85,614.10 delivery order to Amerisourcebergen Drug Corp on February 27, 2026, for Ibrance 75 mg tablets (7-count). The order is issued under Amerisourcebergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, PA. The order has a firm fixed price...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 27, 2026, for Ibrance 100 mg capsules (21-count packaging) with a ceiling value of $8,559.84. Place of performance is Conshohocken, PA. Ultimate completion date is March 20, 2026. The order is priced firm fixed price with no set-aside. The delivery order is issued under the parent IDC held by Cencora, Inc. (AmerisourceBergen's parent organization) with the Defense Logistics Agency Troop Support...